108 related articles for article (PubMed ID: 8955228)
1. Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients.
Vavassori M; Maccario R; Moretta A; Comoli P; Wack A; Locatelli F; Lanzavecchia A; Maserati E; Dellabona P; Casorati G; Montagna D
J Immunol; 1996 Dec; 157(12):5739-47. PubMed ID: 8955228
[TBL] [Abstract][Full Text] [Related]
2. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
Roberts JL; Volkman DJ; Buckley RH
J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604
[TBL] [Abstract][Full Text] [Related]
3. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal analysis of T cells responding to tetanus toxoid in healthy subjects as well as in pediatric patients after bone marrow transplantation: the identification of identical TCR-CDR3 regions in time suggests long-term stability of at least part of the antigen-specific TCR repertoire.
Godthelp BC; van Tol MJ; Vossen JM; van den Elsen PJ
Int Immunol; 2001 Apr; 13(4):507-18. PubMed ID: 11282990
[TBL] [Abstract][Full Text] [Related]
6. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
7. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the T cell repertoire after bone marrow transplantation.
Villers D; Milpied N; Gaschet J; Davodeau F; Hallet MM; Bonneville M; Vié H
Bone Marrow Transplant; 1994 Jan; 13(1):19-26. PubMed ID: 8019449
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of the T cell receptor alpha beta repertoire in recipients of allogeneic BMT.
Rencher SD; Hanif I; Heslop HE; Turner VE; Brenner MK; Hurwitz JL
Bone Marrow Transplant; 1992 Dec; 10(6):521-7. PubMed ID: 1490202
[TBL] [Abstract][Full Text] [Related]
10. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
[TBL] [Abstract][Full Text] [Related]
12. The presence and longevity of peripherally expanded donor-derived TCRalphabeta+ mature T lymphocyte clones after allogeneic bone marrow transplantation for adult myeloid leukemias.
Saitoh H; Hirokawa M; Fujishima N; Ichikawa Y; Kawabata Y; Miura I; Miura AB; Matsutani T; Suzuki R; Sawada K
Leukemia; 2003 Aug; 17(8):1626-35. PubMed ID: 12886252
[TBL] [Abstract][Full Text] [Related]
13. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
[TBL] [Abstract][Full Text] [Related]
14. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
[TBL] [Abstract][Full Text] [Related]
15. Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation.
Teshima T; Liu C; Lowler KP; Dranoff G; Ferrara JL
Cancer Res; 2002 Feb; 62(3):796-800. PubMed ID: 11830535
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantation.
Yurovsky VV; Cottler-Fox MH; Atamas SP; Shanholtz CB; Britt EJ; Sensenbrenner LL; White B
Am J Hematol; 2001 Jan; 66(1):1-11. PubMed ID: 11426485
[TBL] [Abstract][Full Text] [Related]
17. Endogenous CD8+ T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorder.
Khatri VP; Baiocchi RA; Peng R; Oberkircher AR; Dolce JM; Ward PM; Herzig GP; Caligiuri MA
J Immunol; 1999 Jul; 163(1):500-6. PubMed ID: 10384154
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.
Teshima T; Mach N; Hill GR; Pan L; Gillessen S; Dranoff G; Ferrara JL
Cancer Res; 2001 Jan; 61(1):162-71. PubMed ID: 11196155
[TBL] [Abstract][Full Text] [Related]
19. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
Fu YW; Wu DP; Cen JN; Feng YF; Chang WR; Qiu QC; Zhu ZL; Zhu P
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2265-7. PubMed ID: 18001548
[TBL] [Abstract][Full Text] [Related]
20. B cell development and regulation after T cell-depleted marrow transplantation.
Wimperis JZ; Brenner MK; Prentice HG; Thompson EJ; Hoffbrand AV
J Immunol; 1987 Apr; 138(8):2445-50. PubMed ID: 3549902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
